Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Is TB-500 Legal to Purchase for Research?: Comparison

In vitro research by registered institution with documented protocol Legal under 21 CFR 312 Active IRB/IACUC protocol, supplier CoA, 'research use only' labeling Low. Compliant if documentation maintained This is the safest legal pathway. Peptide purchase alig

This comparison does not assign a generated winner or score.

  • In vitro research by registered institution with documented protocol
  • Legal under 21 CFR 312
  • Active IRB/IACUC protocol, supplier CoA, 'research use only' labeling
  • Low. Compliant if documentation maintained
  • This is the safest legal pathway. Peptide purchase aligns with federal research exemptions when intent and documentation are clear
  • Animal model research with institutional oversight
  • Legal under 21 CFR 312 and IACUC standards
  • IACUC-approved protocol, veterinary supervision if required, proper waste disposal
  • Low to moderate. Depends on protocol adherence
  • Legal and common in academic settings. Institutional compliance infrastructure typically handles documentation
  • Personal purchase by individual without research affiliation
  • Grey zone. Legal to purchase, illegal to use for unapproved human administration
  • None enforceable. Buyer intent determines FDA classification risk
  • High. FDA considers this unapproved drug distribution if human use is implied
  • The peptide itself isn't controlled, but purchasing without a research entity creates documentation gaps that suggest non-compliant intent
  • Purchase from supplier making therapeutic claims or providing dosing instructions
  • Illegal. Supplier is distributing unapproved drugs
  • Supplier must not make disease claims or provide human use guidance
  • Very high. Both buyer and seller at risk of FDA enforcement
  • Even if your intent is legitimate research, purchasing from a non-compliant supplier creates a paper trail linking your institution to illegal drug distribution
  • Importation from international supplier without FDA registration
  • Illegal if intended for human use; legal for research if properly documented
  • CBP and FDA import compliance, research entity documentation, proper labeling
  • Moderate to high. Customs may seize shipments lacking clear research documentation
  • International sourcing adds CBP scrutiny. Seizure rates increase significantly if labeling or documentation suggests human use
More references

Related material